3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Myelodysplastic Syndromes
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Hematologic Neoplasms
3
Myeloproliferative Disorders
2
Lymphoma, Non-Hodgkin
2
Leukemia, Biphenotypic, Acute
2
Hodgkin Disease
2
Graft vs Host Disease
2
Ganglioneuroblastoma
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Teratoma
1
Recurrence
1
Neuroblastoma
1
Multiple Myeloma
1
Medulloblastoma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myeloid
1
Leukemia, Mast-Cell
1
Leukemia, Large Granular Lymphocytic
1
Leukemia
1
High Risk Myeloid Malignancies
1
GATA2 Deficiency
1
Choriocarcinoma
1
Carcinoma, Embryonal
1
Interventions
Rituximab
14
Cyclophosphamide
10
Magnetic Resonance Spectroscopy
8
Lenalidomide
8
venetoclax
6
Specimen Handling
6
obinutuzumab
5
ibrutinib
5
Prednisone
5
Biopsy
5
zanubrutinib
4
fludarabine phosphate
4
fludarabine
4
Whole-Body Irradiation
4
Vincristine
4
CT-P10
4
polatuzumab vedotin
3
orelabrutinib
3
Mycophenolic Acid
3
Doxorubicin
3
Cyclosporine
3
Bendamustine Hydrochloride
3
pirtobrutinib
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Busulfan
2
voruciclib
1
treosulfan
1
tafasitamab
1
prednylidene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
Thiotepa
×
90 days
×
Clear all
No trials found.